Scientific validation is essential for the global acceptance of traditional medicine systems like Ayurveda. Discuss with examples.

Ayurveda commands wide domestic use, but global acceptance depends on evidence a regulator anywhere can read. WHO itself frames traditional medicine integration around "stronger evidence to inform regulations ensuring safe and equitable access" [1] — making validation the bridge between heritage and health systems.

Why validation is essential

• Regulatory entry: Foreign drug regulators admit therapies only on proven efficacy, safety and quality; anecdote-based claims cannot clear that bar.
• Safety assurance: Herbo-mineral formulations require documented toxicity, dosage and drug-interaction data before mass use.
• Standardisation: Reproducible phytochemistry and quality control are needed since plant material varies by source and season [3].
• Health-system integration: WHO's push to embed traditional medicine in primary health care and universal health coverage presumes evidence-graded interventions [1][2].
• Countering scepticism: Validation converts "alternative" perception into mainstream credibility, aiding exports and soft power.

Examples of the validation route

• As early as 1976, a joint WHO–ICMR team took up research with the Ayurvedic Trust, Coimbatore on rheumatism — first testing clinical claims, then the pharmacological basis of the drugs [4]: the same evidence-first logic used today.
• ICMR-National Institute of Traditional Medicine, Belagavi conducts scientific evaluation of codified and non-codified herbal medicines — efficacy, safety, mode of action and clinical evaluation [3].
• The WHO Global Traditional Medicine Centre, Jamnagar, works on research methodologies, ICD-11 traditional medicine coding and a knowledge bank [1].
• The WHO Global Summit (New Delhi, 2025) launched a Traditional Medicine Global Library with evidence gap maps and set up an expert advisory group on standards [2].

Persisting challenges

• Randomised trial designs sit awkwardly with personalised, holistic regimens, demanding new methodologies [1].
• Thin funding, weak clinical-trial capacity, and intellectual property concerns of knowledge holders [1].

Validation is thus not a concession to Western science but the language of global trust. Sustained ICMR–AYUSH–WHO research partnerships, evidence gap mapping and harmonised standards can position Ayurveda as a credible pillar of universal health coverage.